[Andujar P, Bensefa-Colas L, Descatha A. (2010). Acute and chronic cadmium poisoning. Rev Med Interne 31: 107-145.]Search in Google Scholar
[Bharavi K, Reddy AG, Rao GS, Kumar PR, Kumar DS, Prasadini PP. (2011). Prevention of cadmium bioaccumulation by herbal adaptogens. Indian J Pharmacol 43: 45-9.]Search in Google Scholar
[Blanusa M, Varnai VM, Piasek M, Kostial K. (2005). Chelators as antidotes of metal toxicity: therapeutic and experimental aspects. Curr Med Chem 12: 2771-94.]Search in Google Scholar
[Blumenthal SS, Ren L, Lewand DL, Krezoski SK, Petering DH. (1998). Cadmium decreases SGLT1 messenger RNA in mouse kidney cells. Toxicol Appl Pharmacol 149: 49-54.]Search in Google Scholar
[Chapatwala KD, Boykin M, Butts A, Rajanna B. (1982). Eff ect of intraperitoneally injected cadmium on renal and hepatic gluconeogenic enzymes in rats. Drug Chem Toxicol 5: 305-17.]Search in Google Scholar
[Donpunha W, Kukongviriyapan U, Sompamit K, Pakdechote P, Kukongviriyapan V, Pannangpetch P. (2011). Protective eff ect of ascorbic acid on cadmium- induced hypertension and vascular dysfunction in mice. Biometals 24: 105-15.]Search in Google Scholar
[Edwards JR and Prozialeck WC. (2009). Cadmium, diabetes and chronic kidney disease. Toxicol Appl Pharmacol 238: 289-93.]Search in Google Scholar
[Flora SJ, Pachauri V. (2010). Chelation in metal intoxication. Int J Environ Res Public Health 7: 2745-88.]Search in Google Scholar
[Hamidinia SA, Erdahl WL, Chapman CJ, Steinbaugh GE, Taylor RW, Pfeiff er DR. (2006). Monensin improves the eff ectiveness of meso-dimercaptosuccinate when used to treat lead intoxication in rats. Environ. Health Persp 114: 484-93.]Search in Google Scholar
[Ivanova J, Pantcheva IN, Mitewa M, Simova S, Mayer-Figge H, Sheldrick WS. (2010). Crystal structures and spectral properties of new Cd(II) and Hg(II) complexes of monensic acid with diff erent coordination modes of the ligand. Cent Eur J Chem 8: 852-860.]Search in Google Scholar
[Ivanova J, Gluhcheva Y, Kamenova K, Arpadjan S, Mitewa M. (2012). The tetraethylammonium salt of monensic acid-An antidote for subacute cadmium intoxication: a study using an ICR mouse model. J Trace Elem Med Biol 26:279-84.]Search in Google Scholar
[Manna P, Sinha M, Sill PC. (2008). Amelioration of cadmium-induced cardiac impairment by taurine. Chem-Biol Inter 174: 88-97.]Search in Google Scholar
[Messner B, Knofl ach M, Seubert A, Ritsch A, Pfaller K, Henderson B, Shen YH, Zeller I, Willeit J, Wick G, Kiechl S, Bernhard D. (2009). Cadmium is a novel and independent risk factor for early atherosclerosis mechanisms and in vivo relevance. Arterioscler Trom Vasc Biol 29: 1392-8.]Search in Google Scholar
[Molloaoglu H, Gokcimen A, Ozguner F, Oktem F, Ahmet K, Hilimi D, Gokalp O, Cicek E. (2006). Caff eic acid phenethyl ester prevents cadmium-induced cardiac impairment in rat. Toxicol 227: 15-20.]Search in Google Scholar
[Nordberg GF. (2004). Cadmium and health in the 21st century--historical remarks and trends for the future. Biometals 17: 485-9.]Search in Google Scholar
[Nordberg GF, Jin T and Nordberg M. (1994). Subcellular targets of cadmium nephrotoxicity: cadmium binding to renal membrane proteins in animals with or without protective metallothionein synthesis. Environ Health Perspect 102(3): 191-4.]Search in Google Scholar
[Nordberg M and Nordberg GF. (2000). Toxicological aspects of metallothionein. Cell Mol Biol 46: 451-63.]Search in Google Scholar
[Peters JL, Perlstein TS, Perry ML, McNeely E, Weuve J. (2010). Cadmium exposure in association with history of stroke and heart failure. Environ Res 110: 199-206.]Search in Google Scholar
[Prozialeck WC, Edwards JR, Nebert DW, Woods JM, Barchowsky A, Atchison WD. (2008). The vascular system as a target of metal toxicity. Toxicol Sci 102: 207-18.]Search in Google Scholar
[Prozialeck WC, Edwards JR, Woods JM. (2006). The vascular endothelium as a target of cadmium toxicity. Life Sci 79: 1493-506.]Search in Google Scholar
[Ross R. (1999). Atherosclerosis--an infl ammatory disease. N Engl J Med 340: 115-26.]Search in Google Scholar
[Satarug S, Nishijo M, Ujjin P, Vanavanitkun Y, Moore MR. (2005). Cadmiuminduced nephropathy in the development of high blood pressure. Toxicol Lett 157: 57-68.]Search in Google Scholar
[Smetana R, Glogar D, Weidinger F, Meisinger V. (1987). Heavy metal and trace element deviations. A comparison of idiopathic dilated cardiomyopathy and coronary heart disease. Wien Med Wochenschr 137: 553-7.]Search in Google Scholar
[Sompamit K, Kukongviriyapan U, Donpunha W, Nakmareong S, Kukongviriyapan V. (2010). Reversal of cadmium-induced vascular dysfunction and oxidative stress by meso-2,3-dimercaptosuccinic acid in mice. Toxicol Lett 198: 77-82.]Search in Google Scholar
[Tellez-Plaza M, Navas-Acien A, Crainiceanu CM, Sharrett AR, Guallar E. (2010). Cadmium and peripheral arterial disease: gender diff erences in the 1999-2004 US National Health and Nutrition Examination Survey. Am J Epidemiol 172: 671-81.]Search in Google Scholar
[Thijssen S, Maringwa J, Faes Ch, Lambrichts I, Kerkhove EV. (2007). Chronic exposure of mice to environmentally relevant, low doses of cadmium leads to early renal damage, not predicted by blood or urine cadmium levels. Toxicol 229: 145-156. ]Search in Google Scholar
